Huanglian Jiedu Wan intervened with "Shi-Re Shanghuo" syndrome through regulating immune balance mediated by biomarker succinate.
Luo K, Zhao H, Wang M, Tian M, Si N, Xia W, Song J, Chen Y, Wang L, Zhang Y, Wei X, Li X, Qin G, Yang J, Wang H, Bian B, Zhou Y.
Luo K, et al.
Clin Immunol. 2024 Jan;258:109861. doi: 10.1016/j.clim.2023.109861. Epub 2023 Dec 6.
Clin Immunol. 2024.
PMID: 38065370
Clinical Trial.